Literature DB >> 4567182

Iron metabolism in Hodgkin's disease.

M R Beamish, P A Jones, D Trevett, I H Evans, A Jacobs.   

Abstract

An evaluation of iron metabolism has been carried out in 23 untreated patients with Hodgkin's disease and 6 patients with other lymphomata. The reduction in red cell life span is related to the stage of the disease. There is an almost universal impairment of iron release from the reticuloendothelial system with a consequent sideropenia and failure of iron delivery to the bone marrow for erythropoiesis. This defect is found in all stages of the disease and is not related to systemic symptoms.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4567182      PMCID: PMC2008667          DOI: 10.1038/bjc.1972.61

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  Anemia in Hodgkin's disease.

Authors:  M J CLINE; N I BERLIN
Journal:  Cancer       Date:  1963-04       Impact factor: 6.860

2.  Reutilization of iron in anemia complicating malignant neoplasma.

Authors:  F I HAURANI; K YOUNG; L M TOCANTINS
Journal:  Blood       Date:  1963-07       Impact factor: 22.113

3.  The mechanism of the anemia associated with Hodgkin's disease.

Authors:  P P GIANNOPOULOS; D E BERGSAGEL
Journal:  Blood       Date:  1959-07       Impact factor: 22.113

4.  The effect of inflammation on the utilization of erythrocyte and transferrin bound radioiron for red cell production.

Authors:  E J FREIREICH; A MILLER; C P EMERSON; J F ROSS
Journal:  Blood       Date:  1957-11       Impact factor: 22.113

5.  A clinical study in Hodgkin's disease.

Authors:  B LEVINSON; B A WALTER; M M WINTROBE; G E CARTWRIGHT
Journal:  AMA Arch Intern Med       Date:  1957-04

6.  [Disorders of the utilization of hemoglobin iron during the developent of Hodgkin's disease].

Authors:  Y Najean; C Dresch; N Ardaillou
Journal:  Nouv Rev Fr Hematol       Date:  1967 Sep-Oct

7.  The measurement of reticuloendothelial iron release using iron-dextran.

Authors:  M R Beamish; A G Davies; J D Eakins; A Jacobs; D Trevett
Journal:  Br J Haematol       Date:  1971-12       Impact factor: 6.998

8.  Characteristics of iron dextran utilization in man.

Authors:  P A Henderson; R S Hillman
Journal:  Blood       Date:  1969-09       Impact factor: 22.113

9.  The preparation of 59 Fe-labelled transferrin for ferrokinetic studies.

Authors:  I Cavill
Journal:  J Clin Pathol       Date:  1971-07       Impact factor: 3.411

10.  METHOD FOR THE AUTOMATIC DETERMINATION OF SERUM IRON.

Authors:  D S YOUNG; J M HICKS
Journal:  J Clin Pathol       Date:  1965-01       Impact factor: 3.411

View more
  15 in total

1.  Suggested models of ecotaxopathy in lymphoreticular malignancy. A role for iron-binding proteins in the control of lymphoid cell migration.

Authors:  M de Sousa; A Smithyman; C Tan
Journal:  Am J Pathol       Date:  1978-02       Impact factor: 4.307

Review 2.  The anaemia of chronic disorders.

Authors:  D Samson
Journal:  Postgrad Med J       Date:  1983-09       Impact factor: 2.401

3.  [Significance of metabolic parameters in Hodgkin's disease (author's transl)].

Authors:  J Oertel; H Gerhartz
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-06-15

Review 4.  Roles of iron in neoplasia. Promotion, prevention, and therapy.

Authors:  E D Weinberg
Journal:  Biol Trace Elem Res       Date:  1992-08       Impact factor: 3.738

5.  [Serum ferritin in differential diagnosis of anemia (author's transl)].

Authors:  J Oertel
Journal:  Klin Wochenschr       Date:  1982-06-01

Review 6.  Iron metabolism during infection and neoplasia.

Authors:  E D Letendre
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 7.  Malignant disease: nutritional implications of disease and treatment.

Authors:  S Holmes; J W Dickerson
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

8.  Iron and neoplasia.

Authors:  E D Weinberg
Journal:  Biol Trace Elem Res       Date:  1981-03       Impact factor: 3.738

9.  Electron spin resonance studies on caeruloplasmin and iron transferrin in patients with chronic lymphocytic leukaemia.

Authors:  J A Green; T Pocklington; A A Dawson; M Foster
Journal:  Br J Cancer       Date:  1980-03       Impact factor: 7.640

10.  Ferritinaemia in leukaemia and Hodgkin's disease.

Authors:  P A Jones; F M Miller; M Worwood; A Jacobs
Journal:  Br J Cancer       Date:  1973-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.